Euphol prevents experimental autoimmune encephalomyelitis in mice: Evidence for the underlying mechanisms

Biochemical Pharmacology

Volumn 83, Issue 4, 2012, Pages 531-542

  Dutra, Rafael Cypriano ^a   De Cezaro De Souza, Paula Roberta ^a   Bento, Allisson Freire ^a   Marcon, Rodrigo ^a   Bicca, Maíra Assunão ^a   Pianowski, Luiz Francisco ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Pianowski and Pianowski Ltda   (Brazil)

Author keywords

Adhesion molecules; Euphol; Experimental autoimmune encephalomyelitis; Multiple sclerosis

Indexed keywords

CELL ADHESION MOLECULE; CYCLOOXYGENASE 2; CYTOKINE; EUPHOL; INDUCIBLE NITRIC OXIDE SYNTHASE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; MYELIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MOUSE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; TH1 CELL; TH17 CELL; WESTERN BLOTTING;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; DRUG ADMINISTRATION SCHEDULE; EATING; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION REGULATION; LANOSTEROL; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; RNA, MESSENGER; T-LYMPHOCYTES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855760663     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.11.026     Document Type: Article

References (73)

1. E.M. Frohman, M.K. Racke, and C.S. Raine Multiple sclerosis - the plaque and its pathogenesis N Engl J Med 354 2006 942 955
2. J.M. McPartland, M. Glass, and R.G. Pertwee Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences Br J Pharmacol 152 2007 583 593 (Pubitemid 350034970)
3. J. Goverman Autoimmune T cell responses in the central nervous system Nat Rev Immunol 2009
4. D.A. Hafler Multiple sclerosis. IFN-γ, TNF-α Clin Invest 113 2004 788 794
5. L. Steinman A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage Nat Med 13 2007 139 145
6. A. Prat, K. Biernacki, S. Pouly, J. Nalbantoglu, R. Couture, and J.P. Antel Kinin B1 receptor expression and function on human brain endothelial cells J Neuropathol Exp Neurol 59 2000 896 906
7. H.F. McFarland, and R. Martin Multiple sclerosis: a complicated picture of autoimmunity Nat Immunol 8 2007 913 919 (Pubitemid 47300005)
8. J. Sellner, J. Kraus, A. Awad, R. Milo, B. Hemmer, and O. Stuve The increasing incidence and prevalence of female multiple sclerosis - a critical analysis of potential environmental factors Autoimmun Rev 10 2011 495 502
9. S.E. Baranzini, J. Mudge, J.C. van Velkinburgh, P. Khankhanian, I. Khrebtukova, and N.A. Miller Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis Nature 464 2010 1351 1356
10. M. Sospedra, and R. Martin Immunology of multiple sclerosis Annu Rev Immunol 23 2005 683 747 (Pubitemid 40563183)
11. L.A. Betancur-Galvis, G.E. Morales, J.E. Forero, and J. Roldan Cytotoxic and antiviral activities of Colombian medicinal plant extracts of the Euphorbia genus Mem Inst Oswaldo Cruz 97 2002 541 546 (Pubitemid 135746800)
12. A.A. Rahuman, G. Gopalakrishnan, P. Venkatesan, and K. Geetha Larvicidal activity of some Euphorbiaceae plant extracts against Aedes aegypti and Culex quinquefasciatus (Diptera: Culicidae) Parasitol Res 102 2008 867 873
13. M.D. Van Sickle, M. Duncan, P.J. Kingsley, A. Mouihate, P. Urbani, and K. Mackie Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 310 2005 329 332 (Pubitemid 41457202)
14. K. Yasukawa, T. Akihisa, Z.Y. Yoshida, and M. Takido Inhibitory effect of euphol, a triterpene alcohol from the roots of Euphorbia kansui, on tumour promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin J Pharm Pharmacol 52 2000 119 124 (Pubitemid 30125293)
15. S. Bani, A. Kaul, B.S. Jaggi, K.A. Suri, O.P. Suri, and O.P. Sharma Anti-inflammatory activity of the hydrosoluble fraction of Euphorbia royleana latex Fitoterapia 71 2000 655 662
16. S. Bani, A. Kaul, B. Khan, S.F. Ahmad, K.A. Suri, and N.K. Satti Immunosuppressive properties of an ethyl acetate fraction from Euphorbia royleana J Ethnopharmacol 99 2005 185 192 (Pubitemid 40724392)
17. I.M. Stromnes, and J.M. Goverman Active induction of experimental allergic encephalomyelitis Nat Protoc 1 2006 1810 1819 (Pubitemid 46773300)
18. T. Akihisa, K. Yasukawa, Y. Kimura, S. Takase, S. Yamanouchi, and T. Tamura Triterpene alcohols from camellia and sasanqua oils and their anti-inflammatory effects Chem Pharm Bull (Tokyo) 45 1997 2016 2023 (Pubitemid 28047313)
19. L. Minghetti Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases J Neuropathol Exp Neurol 63 2004 901 910 (Pubitemid 39202493)
20. J.S. Tzartos, M.A. Friese, M.J. Craner, J. Palace, J. Newcombe, and M.M. Esiri Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis Am J Pathol 172 2008 146 155 (Pubitemid 351186376)
21. A.V. Andjelkovic, and J.S. Pachter Central nervous system endothelium in neuroinflammatory, neuroinfectious, and neurodegenerative disease J Neurosci Res 51 1998 423 430 (Pubitemid 28106703)
22. T.A. Samad, K.A. Moore, A. Sapirstein, S. Billet, A. Allchorne, and S. Poole Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity Nature 410 2001 471 475 (Pubitemid 32240046)
23. S. Man, E.E. Ubogu, and R.M. Ransohoff Inflammatory cell migration into the central nervous system: a few new twists on an old tale Brain Pathol 17 2007 243 250 (Pubitemid 46466143)
24. N.J. Abbott, A.A. Patabendige, D.E. Dolman, S.R. Yusof, and D.J. Begley Structure and function of the blood-brain barrier Neurobiol Dis 37 2010 13 25
25. L. Bo, J.W. Peterson, S. Mork, P.A. Hoffman, W.M. Gallatin, and R.M. Ransohoff Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions J Neuropathol Exp Neurol 55 1996 1060 1072 (Pubitemid 26338018)
26. M. Gunnarsson, C. Malmestrom, M. Axelsson, P. Sundstrom, C. Dahle, and M. Vrethem Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab Ann Neurol 69 2011 83 89
27. L.J. Barten, D.R. Allington, K.A. Procacci, and M.P. Rivey New approaches in the management of multiple sclerosis Drug Des Dev Ther 4 2011 343 366
28. R. Zhang, A. Tian, H. Zhang, Z. Zhou, H. Yu, and L. Chen Amelioration of experimental autoimmune encephalomyelitis by beta-elemene treatment is associated with Th17 and Treg cell balance J Mol Neurosci 44 2011 31 40
29. M.L. De Paula, D.H. Rodrigues, H.C. Teixeira, M.M. Barsante, M.A. Souza, and A.P. Ferreira Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis Int Immunopharmacol 8 2008 1291 1297
30. R. Zhang, A. Tian, X. Shi, H. Yu, and L. Chen Downregulation of IL-17 and IFN-gamma in the optic nerve by beta-elemene in experimental autoimmune encephalomyelitis Int Immunopharmacol 10 2010 738 743
31. R. Martin, J. Carvalho-Tavares, M. Hernandez, M. Arnes, V. Ruiz-Gutierrez, and M.L. Nieto Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role Biochem Pharmacol 79 2010 198 208
32. X. Ma, Y. Jiang, A. Wu, X. Chen, R. Pi, and M. Liu Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice PLoS One 5 2010 e13489
33. R.C. Dutra, R.F. Claudino, A.F. Bento, R. Marcon, E.C. Schmidt, and Z.L. Bouzon Preventive and therapeutic euphol treatment attenuates experimental colitis in mice PLoS One 6 2011 e27122
34. Y. Dong, and E.N. Benveniste Immune function of astrocytes Glia 36 2001 180 190 (Pubitemid 33055906)
35. C. Farina, F. Aloisi, and E. Meinl Astrocytes are active players in cerebral innate immunity Trends Immunol 28 2007 138 145 (Pubitemid 46283692)
36. M. Feldmann, and L. Steinman Design of effective immunotherapy for human autoimmunity Nature 435 2005 612 619 (Pubitemid 40825501)
37. J.M. Fletcher, S.J. Lalor, C.M. Sweeney, N. Tubridy, and K.H. Mills T cells in multiple sclerosis and experimental autoimmune encephalomyelitis Clin Exp Immunol 162 2010 1 11
38. C. Jack, F. Ruffini, A. Bar-Or, and J.P. Antel Microglia and multiple sclerosis J Neurosci Res 81 2005 363 373 (Pubitemid 41359291)
39. M.K. Sharief, and E.J. Thompson In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis J Neuroimmunol 38 1992 27 33
40. P. Megyeri, C.S. Abraham, P. Temesvari, J. Kovacs, T. Vas, and C.P. Speer Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets Neurosci Lett 148 1992 137 140 (Pubitemid 23007723)
41. W.S. Begolka, C.L. Vanderlugt, S.M. Rahbe, and S.D. Miller Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis J Immunol 161 1998 4437 4446 (Pubitemid 28469031)
42. R. Pannu, and I. Singh Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms Neurochem Int 49 2006 170 182 (Pubitemid 43867075)
43. H. Koprowski, Y.M. Zheng, E. Heber-Katz, N. Fraser, L. Rorke, and Z.F. Fu In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases Proc Natl Acad Sci USA 90 1993 3024 3027 (Pubitemid 23113550)
44. K. Schnizler, L.P. Shutov, M.J. Van Kanegan, M.A. Merrill, B. Nichols, and G.S. McKnight Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons J Neurosci 28 2008 4904 4917
45. A.H. Cross, T.P. Misko, R.F. Lin, W.F. Hickey, J.L. Trotter, and R.G. Tilton Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice J Clin Invest 93 1994 2684 2690 (Pubitemid 24177187)
46. J.P. Eiserich, M. Hristova, C.E. Cross, A.D. Jones, B.A. Freeman, and B. Halliwell Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils Nature 391 1998 393 397 (Pubitemid 28093514)
47. D. Trotti, D. Rossi, O. Gjesdal, L.M. Levy, G. Racagni, and N.C. Danbolt Peroxynitrite inhibits glutamate transporter subtypes J Biol Chem 271 1996 5976 5979 (Pubitemid 26095396)
48. I. Gutcher, and B. Becher APC-derived cytokines and T cell polarization in autoimmune inflammation J Clin Invest 117 2007 1119 1127 (Pubitemid 46718396)
49. H.S. Panitch, R.L. Hirsch, A.S. Haley, and K.P. Johnson Exacerbations of multiple sclerosis in patients treated with gamma interferon Lancet 1 1987 893 895
50. D.J. Cua, J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, and B. Seymour Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 2003 744 748 (Pubitemid 36227625)
51. M.J. McGeachy, Y. Chen, C.M. Tato, A. Laurence, B. Joyce-Shaikh, and W.M. Blumenschein The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo Nat Immunol 10 2009 314 324
52. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 Cells Annu Rev Immunol 27 2009 485 517
53. L. Yang, D.E. Anderson, C. Baecher-Allan, W.D. Hastings, E. Bettelli, and M. Oukka IL-21 and TGF-beta are required for differentiation of human T(H)17 cells Nature 454 2008 350 352
54. A.V. Rachitskaya, A.M. Hansen, R. Horai, Z. Li, R. Villasmil, and D. Luger Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion J Immunol 180 2008 5167 5171
55. N. Stella, P. Schweitzer, and D. Piomelli A second endogenous cannabinoid that modulates long-term potentiation Nature 388 1997 773 778 (Pubitemid 27375156)
56. K. Ichiyama, H. Yoshida, Y. Wakabayashi, T. Chinen, K. Saeki, and M. Nakaya Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat J Biol Chem 283 2008 17003 17008
57. N. Manel, D. Unutmaz, and D.R. Littman The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat Nat Immunol 9 2008 641 649 (Pubitemid 351714729)
58. X. Hu, J.E. Wohler, K.J. Dugger, and S.R. Barnum beta2-integrins in demyelinating disease: not adhering to the paradigm J Leukoc Biol 87 2010 397 403
59. B. Engelhardt, and R.M. Ransohoff The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms Trends Immunol 26 2005 485 495 (Pubitemid 41139258)
60. J.I. Alvarez, R. Cayrol, and A. Prat Disruption of central nervous system barriers in multiple sclerosis Biochim Biophys Acta 1812 2011 252 264
61. W.A. Muller Leukocyte-endothelial cell interactions in the inflammatory response Lab Invest 82 2002 521 533 (Pubitemid 34522364)
62. T.M. Carlos, and J.M. Harlan Leukocyte-endothelial adhesion molecules Blood 84 1994 2068 2101 (Pubitemid 24296363)
63. J. Takagi, and T.A. Springer Integrin activation and structural rearrangement Immunol Rev 186 2002 141 163
64. N. Hogg, R. Henderson, B. Leitinger, A. McDowall, J. Porter, and P. Stanley Mechanisms contributing to the activity of integrins on leukocytes Immunol Rev 186 2002 164 171
65. B. Cannella, A.H. Cross, and C.S. Raine Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis J Neuroimmunol 46 1993 43 55
66. E.J. Gordon, K.J. Myers, J.P. Dougherty, H. Rosen, and Y. Ron Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis J Neuroimmunol 62 1995 153 160
67. S. Brocke, C. Piercy, L. Steinman, I.L. Weissman, and T. Veromaa Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment Proc Natl Acad Sci USA 96 1999 6896 6901 (Pubitemid 29274981)
68. A. Lourbopoulos, N. Grigoriadis, R. Lagoudaki, O. Touloumi, E. Polyzoidou, and I. Mavromatis Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis Brain Res 1390 2011 126 141
69. E. Kozela, N. Lev, N. Kaushansky, R. Eilam, N. Rimmerman, and R. Levy Cannabidiol inhibits pathogenic T-cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57bl/6 mice Br J Pharmacol 2011
70. J. Palazuelos, N. Davoust, B. Julien, E. Hatterer, T. Aguado, and R. Mechoulam The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis J Biol Chem 283 2008 13320 13329
71. A.J. Sanchez, P. Gonzalez-Perez, I. Galve-Roperh, and A. Garcia-Merino R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4 -benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor Biochem Pharmacol 72 2006 1697 1706 (Pubitemid 44765005)
72. A.R. King, E.Y. Dotsey, A. Lodola, K.M. Jung, A. Ghomian, and Y. Qiu Discovery of potent and reversible monoacylglycerol lipase inhibitors Chem Biol 16 2009 1045 1052
73. R.C. Dutra, K.B. Silva, A.F. Bento, A.F. Paszcuk, R. Marcon, and F.C. Meotti Euphol, a novel cannabinoid agonist, prevents inflammatory and neuropathic persistent pain in rodents Planta Med 77 2011 1254